The Office of Health Insurance Programs of the State Department of Health has approved the release of the August 2024 Medicaid Update. Included in this month’s update:
- New York State Medicaid Pharmacy Policy for Coronavirus Disease 2019 Testing
- New York State Medicaid Coverage for Coronavirus Disease 2019 Vaccines for Eligible Vaccine For Children Program Members at the Pharmacy
- Introduction to Upcoming Pharmacy and Practitioner Administered Drug Changes Due to Enacted Budget
Also in New York, on September 23, 2024, the Medicaid Program made important changes to the coverage of blood glucose testing supplies, aligning with Medicare coverage criteria. This update is designed to promote effective testing habits to support individuals managing their diabetes. Changes to the supply limits for test strips and lancets and the implications for pharmacies and healthcare providers, are explained below:
Effective October 1, 2024, the Medicaid blood glucose testing supply coverage will align with Medicare policies. The new guidelines are as follows:
- Members using insulin: Those who require insulin for blood glucose management will be eligible to receive up to 300 test strips and 300 lancets every three months.
- Members not using insulin: For individuals managing their diabetes without insulin, the allowance will be up to 100 test strips and 100 lancets every three months.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.